The Case Covaxin, also known as Covaxgate, refers to an investigation made by the Brazilian Federal Public Ministry (MPF), held on 16 June 2021, which found evidence of irregularities in the purchase of 20 million doses by the Ministry of Health of the Indian vaccine Covaxin, with the value of the vaccines 1000% higher than initially foreseen.

[5] An investigation by the Federal Public Ministry (MPF), conducted on 16 June 2021, found evidence of irregularities in the purchase of 20 million doses of the vaccine through the pharmaceutical company Precisa Medicamentos, with the value of the vaccines 1000% higher than the initial value shown initially by Bharat Biotech six months earlier.

[9] After suspecting corruption in the Covaxin purchase, the congressman and the civil servant claim that they would have met with President Bolsonaro.

[11] By determination of the STF minister Dias Toffoli and appreciated by the COVID-19 CPI, the Federal Police searched the headquarters of Precisa Medicamentos in São Paulo.

[15][16] On 5 February 2021, the National Health Surveillance Agency (Anvisa) announced that it had received an application to study the vaccine in Brazil.